{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:57:16Z","timestamp":1790402236764,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.ctro.2021.04.005","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T14:43:06Z","timestamp":1619102586000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged\u00a0\u2265\u00a060\u00a0years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial"],"prefix":"10.1016","volume":"29","author":[{"given":"Jean-Michel","family":"Hannoun-Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chamorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Boulahssass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba","family":"Polgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vratislav","family":"Strnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.ctro.2021.04.005_b0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ctro.2021.04.005_b0010","doi-asserted-by":"crossref","unstructured":"EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale, P., Taylor, C., Correa, C., Cutter, D., Duane, F., et al., 2014 Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: Meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:9935, 2127\u20132235.","DOI":"10.1016\/S0140-6736(14)60488-8"},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1470-2045(14)71156-8","volume":"16","author":"Bartelink","year":"2015","journal-title":"Lancet Oncol."},{"issue":"9618","key":"10.1016\/j.ctro.2021.04.005_b0020","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"371","author":"Trialists' Group","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctro.2021.04.005_b0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N. Engl .J. Med."},{"issue":"10099","key":"10.1016\/j.ctro.2021.04.005_b0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2021.04.005_b0035","doi-asserted-by":"crossref","unstructured":"A.M. Brunt, J.S. Haviland, D.A. Wheatley, M.A. Sydenham, A. Alhasso, D.J. Bloomfield, C. Chan, M. Churn, S. Cleator, C.E. Coles, A. Goodman, A. Harnett, P. Hopwood, A.M. Kirby, C.C. Kirwan, C. Morris, Z. Nabi, E. Sawyer, N. Somaiah, L. Stones, I. Syndikus, J.M. Bliss, J.R. Yarnold, on behalf of the FAST-Forward Trial Management Group. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6.","DOI":"10.1016\/S0140-6736(20)30932-6"},{"key":"10.1016\/j.ctro.2021.04.005_b0040","doi-asserted-by":"crossref","unstructured":"B.V. Offersen, J. Alsner, H.M. Nielsen, E.H. Jakobsen, M.H. Nielsen, M. Krause, L. Stenbygaard, I. Mjaaland, A. Schreiber, U.M. Kasti, J. Overgaard; Danish Breast Cancer Group Radiation Therapy Committee. Hypofractionated versus standard fractionated radiotherapy in patients with early breast cancer or ductal carcinoma in situ in a randomized phase iii trial: The DBCG HYPO trial. J. Clin. Oncol. 2020 38(31):3615\u20133625. doi:10.1200\/JCO.20.01363. Epub 2020 Sep 10. PMID: 32910709.","DOI":"10.1200\/JCO.20.01363"},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2011.06.026","article-title":"First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015)","volume":"100","author":"Trialists","year":"2011","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2021.04.005_b0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S1470-2045(08)70077-9","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: A randomised trial","volume":"9","author":"Trialists' Group","year":"2008","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.ctro.2021.04.005_b0055","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ctro.2021.04.005_b0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ctrv.2004.06.009","article-title":"Partial breast irradiation: Revolution or evolution?","volume":"30","author":"Hannoun-Levi","year":"2004","journal-title":"Cancer Treat Rev."},{"issue":"3","key":"10.1016\/j.ctro.2021.04.005_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"Polg\u00e1r","year":"2010","journal-title":"Radiother. Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2021.04.005_b0070","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","article-title":"Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO)","volume":"74","author":"Smith","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0075","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","article-title":"The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation","volume":"17","author":"Shah","year":"2018","journal-title":"Brachytherapy."},{"issue":"10015","key":"10.1016\/j.ctro.2021.04.005_b0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(15)00471-7","volume":"387","author":"Strnad","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1470-2045(17)30011-6","volume":"18","author":"Polg\u00e1r","year":"2017","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ctro.2021.04.005_b0090","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(18)30195-5","volume":"19","author":"Sch\u00e4fer","year":"2018","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ctro.2021.04.005_b0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ijrobp.2020.11.006","article-title":"Breast-conserving surgery followed by partial or whole breast irradiation: Twenty-year results of a phase 3 clinical study","volume":"109","author":"Polg\u00e1r","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"13","key":"10.1016\/j.ctro.2021.04.005_b0100","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): A randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctro.2021.04.005_b0105","first-page":"1","article-title":"Single-dose intraoperative radiotherapy during lumpectomy for breast cancer: An innovative patient-centred treatment","author":"Vaidya","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.ctro.2021.04.005_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.ijrobp.2013.08.046","article-title":"Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation","volume":"87","author":"Rodr\u00edguez","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"32","key":"10.1016\/j.ctro.2021.04.005_b0115","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","article-title":"Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy","volume":"31","author":"Olivotto","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"10215","key":"10.1016\/j.ctro.2021.04.005_b0120","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): A randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.ctro.2021.04.005_b0125","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: A randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0130","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ijrobp.2009.04.070","article-title":"Accelerated partial breast irradiation with IMRT: New technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial","volume":"77","author":"Livi","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"35","key":"10.1016\/j.ctro.2021.04.005_b0135","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: Long-term results of the randomized phase III APBI-IMRT-florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2021.04.005_b0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.ijrobp.2019.03.025","article-title":"In Regard to Khan et al","volume":"104","author":"Hannoun-Levi","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ctro.2021.04.005_b0145","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.ijrobp.2019.04.018","article-title":"In regard to Jethwa et al","volume":"104","author":"Hannoun-Levi","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ctro.2021.04.005_b0150","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.semradonc.2008.04.005","article-title":"The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery","volume":"18","author":"Kirkpatrick","year":"2008","journal-title":"Semin. Radiat. Oncol."},{"issue":"9","key":"10.1016\/j.ctro.2021.04.005_b0155","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/bjs.6208","article-title":"Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer","volume":"95","author":"Sacchini","year":"2008","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0160","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2016.04.035","article-title":"A novel form of breast intraoperative radiation therapy with CT-guided high-dose-rate brachytherapy: Results of a prospective phase 1 clinical trial","volume":"96","author":"Showalter","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-1119-6","article-title":"Single fraction of accelerated partial breast irradiation in the elderly:early clinical outcome","volume":"13","author":"Kinj","year":"2018","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.brachy.2017.11.008","article-title":"Accelerated partial breast irradiation for suitable elderly women using a single fraction of multicatheter interstitial high-dose-rate brachytherapy: Early results of the single-fraction elderly breast irradiation (SiFEBI) phase I\/II trial","volume":"17","author":"Hannoun-L\u00e9vi","year":"2018","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/jcb.2018.73994","article-title":"Accelerated partial breast irradiation in a single 18 Gy fraction with high-dose-rate brachytherapy: Preliminary results","volume":"10","author":"Latorre","year":"2018","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.ctro.2021.04.005_b0180","article-title":"Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly","author":"Kinj","year":"2019141234","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brachy.2019.10.007","article-title":"Accelerated partial breast irradiation in the elderly: 5-Year results of the single fraction elderly breast irradiation (SiFEBI) phase I\/II trial","volume":"19","author":"Hannoun-L\u00e9vi","year":"2020","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ctro.2021.04.005_b0190","article-title":"Very accelerated partial breast irradiation phase I\/II multicenter trial vAPBI: Feasability and early results","author":"Guinot","year":"2020","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2018.12.025","article-title":"Three-fraction intracavitary accelerated partial breast brachytherapy: Early provider and patient-reported outcomes of a novel regimen","volume":"104","author":"Jethwa","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ctro.2021.04.005_b0200","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1245\/s10434-012-2671-1","article-title":"Dosimetric feasibility and acute toxicity in a prospective trial of ultrashort-course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device","volume":"20","author":"Khan","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijrobp.2018.12.050","article-title":"Three-fraction accelerated partial breast irradiation (apbi) delivered with brachytherapy applicators is feasible and safe: First results from the triumph-T trial","volume":"104","author":"Khan","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.ctro.2021.04.005_b0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/COC.0000000000000402","article-title":"Six-year results from a phase i\/ii trial for hypofractionated accelerated partial breast irradiation using a 2-day dose schedule","volume":"41","author":"Wilkinson","year":"2018","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0215","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5114\/jcb.2012.27947","article-title":"Dose gradient impact on equivalent dose at 2 Gy for high dose rate interstitial brachytherapy","volume":"4","author":"Hannoun-Levi","year":"2012","journal-title":"J. Contemp. Brachytherapy"},{"key":"10.1016\/j.ctro.2021.04.005_b0220","unstructured":"World health organization. International agency for research on cancer. Globocan. http:\/\/gco.iarc.fr\/tomorrow\/graphic-line?type=0&population=900&mode=population&sex=2&cancer=39&age_group=65%2B&apc_male=0&apc_female=0. Access on line 02\/20\/20."},{"key":"10.1016\/j.ctro.2021.04.005_b0225","unstructured":"United Nations \u2013 UN projects world population to reach 8.5 billion by 2030, driven by growth in developing countries. 2015. https:\/\/news.un.org\/en\/story\/2015\/07\/505352-un-projects-world-population-reach-85-billion-2030-driven-growth-developing#.WNfKh3fpM_U. Access on line 02\/20\/20."},{"key":"10.1016\/j.ctro.2021.04.005_b0230","unstructured":"United Nations. Department of Economic and social affairs. World population ageing 2019. https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2019-Highlights.pdf. Access on line 02\/20\/20."},{"issue":"Suppl 3","key":"10.1016\/j.ctro.2021.04.005_b0235","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1245\/s10434-019-07762-5","article-title":"Radiation therapy after breast-conserving surgery in women 70 years of age and older: How wisely do we choose? In regard to Downs-Canner et al.","volume":"26","author":"Hannoun-Levi","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2021.04.005_b0240","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1056\/NEJMoa040595","article-title":"Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer","volume":"351","author":"Fyles","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ctro.2021.04.005_b0245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Cancer and Leukemia Group B; Radiation Therapy Oncology Group; Eastern Cooperative Oncology Group. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0250","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijrobp.2006.12.045","article-title":"Austrian Breast and Colorectal Cancer Study Group. Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer","volume":"68","author":"P\u00f6tter","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.ctro.2021.04.005_b0255","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): A randomised controlled trial","volume":"16","author":"Kunkler","year":"2015","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0260","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1245\/s10434-013-3233-x","article-title":"Breast-conservative surgery with and without radiotherapy in patients aged 55\u201375 years with early-stage breast cancer: A prospective, randomized, multicenter trial analysis after 108 months of median follow-up","volume":"21","author":"Tinterri","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13014-017-0796-x","article-title":"The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer: a meta-analysis of randomized trials","volume":"12","author":"Matuschek","year":"2017","journal-title":"Radiat. Oncol."},{"issue":"12","key":"10.1016\/j.ctro.2021.04.005_b0270","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jnci\/djy128","article-title":"CISNET-BOLD Collaborative Group. Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast cancer","volume":"110","author":"Jayasekera","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ctro.2021.04.005_b0275","unstructured":"EXamining PErsonalised Radiation Therapy for Low-risk Early Breast cancer (EXPERT). ClinicalTrials.gov Identifier: NCT02889874. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02889874?term=EXPERT&cond=Breast+Cancer&draw=2&rank=1."},{"key":"10.1016\/j.ctro.2021.04.005_b0280","unstructured":"DBCG RT Natural Trial: Partial Breast Versus no Irradiation for Women >=60 Years Operated With Breast Conservation for an Early Breast Cancer: a Clinically Controlled Randomized Phase III Trial. ClinicalTrials.gov Identifier: NCT03646955. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03646955."},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jgo.2020.07.013","volume":"12","author":"Meattini","year":"2021","journal-title":"J. Geriatr. Oncol."},{"key":"10.1016\/j.ctro.2021.04.005_b0290","doi-asserted-by":"crossref","unstructured":"de Boer, A.Z., Bastiaannet, E., de Glas, N.A., Marang-van de Mheen P.J., Dekkers, O.M., et al., 2019 Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer. Breast Cancer Res. Treat. 17(3), 637\u2013645. 10.1007\/s10549-019-05412-8 (Epub 2019 Aug 26 PMID:31451977 PMCID:PMC6817758).","DOI":"10.1007\/s10549-019-05412-8"},{"key":"10.1016\/j.ctro.2021.04.005_b0295","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.clon.2016.06.007","article-title":"It\u2019s PRIMETIME Postoperative avoidance of radiotherapy: biomarker selection of women at very low risk of local recurrence","volume":"28","author":"Kirwan","year":"2016","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.ctro.2021.04.005_b0300","unstructured":"IDEA Study (Individualized Decisions for Endocrine Therapy Alone). ClinicalTrials.gov Identifier: NCT02400190. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02400190?term=Reshma+Jagsi&cond=Breast+Cancer&draw=2&rank=3."},{"key":"10.1016\/j.ctro.2021.04.005_b0305","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.breast.2016.07.022","article-title":"Over-irradiation","volume":"31","author":"Poortmans","year":"2017","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.ctro.2021.04.005_b0310","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.brachy.2017.06.006","article-title":"Accelerated partial breast irradiation for elderly women with early breast cancer: A compromise between whole breast irradiation and omission of radiotherapy","volume":"16","author":"Sumodhee","year":"2017","journal-title":"Brachytherapy"},{"issue":"5","key":"10.1016\/j.ctro.2021.04.005_b0315","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2019.07.052","article-title":"Lumpectomy plus hormone or radiation therapy alone for women aged 70 years or older with hormone receptor-positive early stage breast cancer in the modern era: An analysis of the National Cancer Database","volume":"105","author":"Buszek","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ctro.2021.04.005_b0320","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2019.06.014","article-title":"Radiation therapy without hormone therapy for women age 70 or above with low-risk early breast cancer: A microsimulation","volume":"105","author":"Ward","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0325","first-page":"CD012988","article-title":"Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer","volume":"1","author":"Roberts","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"issue":"11","key":"10.1016\/j.ctro.2021.04.005_b0330","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/annonc\/mdz298","article-title":"Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: A prospective patient-reported outcomes analysis","volume":"30","author":"Ferreira","year":"2019","journal-title":"Ann Oncol."},{"issue":"21","key":"10.1016\/j.ctro.2021.04.005_b0335","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2015.63.8619","article-title":"Treatment adherence and its impact on disease-free survival in the breast international group 1\u201398 trial of tamoxifen and letrozole, alone and in sequence","volume":"34","author":"Chirgwin","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ctro.2021.04.005_b0340","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.ejca.2013.02.031","article-title":"Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial","volume":"49","author":"Blamey","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ctro.2021.04.005_b0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.radonc.2020.09.017","article-title":"Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study","volume":"154","author":"Kurian","year":"2021","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2021.04.005_b0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5152\/ejbh.2019.4997","article-title":"Prevalence of molecular subtypes of breast cancer: A single institutional experience of 2062 patients","volume":"16","author":"Pandit","year":"2019","journal-title":"Eur. J. Breast Health"},{"key":"10.1016\/j.ctro.2021.04.005_b0355","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ctro.2021.04.005_b0360","doi-asserted-by":"crossref","unstructured":"J.M. Hannoun-L\u00e9vi, L. Montagne, S. Sumodhee, R. Schiappa, R. Boulahssass, M. Gautier, J. Gal, M.E. Chand ME. APBI versus ultra APBI in the elderly with low-risk breast cancer: A comparative analysis of oncological outcome and late toxicity. IJROBP 2021 (in press).","DOI":"10.1016\/S0167-8140(21)06267-8"},{"key":"10.1016\/j.ctro.2021.04.005_b0365","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0360-3016(79)90729-6","article-title":"Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast","volume":"5","author":"Harris","year":"1979","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630821000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:07:43Z","timestamp":1762502863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630821000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":73,"alternative-id":["S2405630821000422"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2021.04.005","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine therapy with accelerated Partial breast irradiatiOn or exclusive ultra-accelerated Partial breast irradiation for women aged\u00a0\u2265\u00a060\u00a0years with Early-stage breast cancer (EPOPE): The rationale for a GEC-ESTRO randomized phase III-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2021.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}]}}